Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis

Efficacy of infliximab therapy for arthritis after restorative proctocolectomy in patients with ulcerative colitis - Efficacy of infliximab for arthritis after colectomy in ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013371

Enrollment

Registered

2014-03-07

Start date

2013-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

infliximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Arthritis patients with ulcerative colitis after colectomy

Exclusion criteria

Exclusion criteria: Patients with pre-existing malignancy, other infectious disease, heart failure, or infusion reaction for infliximab

Design outcomes

Primary

Measure	Time frame
Evaluate the degree of arthritis according to Bath Ankylosing Spndylitis Disease Activity Index (BASDAI) during treatment with infliximab	—

Countries

Japan

Contacts

Public ContactMotoi Uchino

Hyogo college of medicine Inflammatory bowel disease center

uchino2s@hyo-med.ac.jp0798-45-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026